GAITHERSBURG, Md., Oct. 26, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that its infectious disease portfolio will be featured in one oral presentation and 5 poster sessions at IDWeek 2016, which takes place from October 26-30 in New Orleans, LA.
The oral presentation, given by Jacqueline Reuben, Senior Infectious Disease Epidemiologist, District of Columbia Department of Health, will illustrate OpGen’s Acuitas Lighthouse® MDRO Management System capabilities in a regional prevalence study, called HARP-DC, of multi-drug resistant organisms (MDROs) in Washington, D.C. healthcare facilities. Additional data presented will highlight:
“The data presented at IDWeek demonstrate OpGen’s commitment to arming hospitals and health systems with the next generation of genomic and informatics solutions to resolve often underestimated infectious disease threats,” said Evan Jones, CEO and Chairman of OpGen. “With these data, we are demonstrating our capabilities to assist in the fight against antimicrobial resistance and the importance of implementing effective preventative frameworks across all health systems.”
The scheduled times and titles of the poster sessions and presentation are as follows:
Thursday, October 27 from 12:30 PM – 2:00 PM CDT
Saturday, October 29 from 12:30 PM – 2:00 PM CDT
Saturday, October 29 at 2:00 PM CDT – Oral Presentation
In addition to these data presentations, initial data from the Intermountain Healthcare retrospective study evaluating the shift in epidemiology in drug resistant organisms over an eight-year period will be presented on Thursday, October 27 at 12:30 p.m. CDT by Dr. Bert Lopansri, lead author of the study at Intermountain Medical Center. He will also host a discussion of the study and its results at the Learning Lounge. The discussion is titled, “Antibiotic resistant bacteria in our Integrated Healthcare Network: are new diagnostic tests needed?” and will take place on Saturday, October 29, 2016 from 1:15 p.m. to 1:45 p.m. CDT at booth #1300.
OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. Learn more at www.opgen.com and follow OpGen on Twitter and LinkedIn.
Last updated on: 27/10/2016
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.